Table 4. Association results between the SNPs in the VEGF gene and the protein levels in the detection samples.
SNP | Campora (N = 42) | Gioi (N = 49) | Cardile (N = 45) | ||||||
MAF | Effect (CI 95%) | p-value | MAF | Effect (CI 95%) | p-value | MAF | Effect (CI 95%) | p-value | |
rs699947 * | 0.41 | −0.19 (−0.71; 0.34) | 0.486 | 0.43 | −0.22 (−0.66; 0.23) | 0.339 | 0.44 | −0.01(−0.45; 0.43) | 0.961 |
rs833061 * | 0.42 | −0.18 (−0.56; 0.20) | 0.353 | 0.50 | 0.26 (−0.22; 0.74) | 0.287 | 0.50 | −0.10 (−0.62; 0.43) | 0.715 |
rs1570360 * | G = 0.46 | 0.17 (−0.18; 0.53) | 0.331 | A = 0.39 | 0.46 (0.01; 0.92) | 0.043 | A = 0.32 | −0.12 (−0.73; 0.48) | 0.696 |
rs2010963 * | 0.43 | −0.06 (−0.55; 0.43) | 0.799 | 0.35 | 0.04 (−0.39; 0.48) | 0.840 | 0.40 | −0.43 (−0.90; 0.04) | 0.070 |
rs25648 * | 0.08 | 1.34 (0.49; 2.20) | 2.11E-03 | 0.08 | 0.64 (−0.04; 1.33) | 0.066 | 0.20 | −0.05 (−0.62; 0.52) | 0.862 |
rs2146323 | 0.33 | −0.16 (−0.70; 0.38) | 0.555 | 0.19 | −0.83 (−1.35; −0.32) | 1.55E-03 | 0.28 | −0.34 (−0.94; 0.27) | 0.275 |
rs3025020 | 0.46 | 0.95 (0.53; 1.37) | 1.01E-05 | 0.26 | 0.21 (−0.30; 0.72) | 0.414 | 0.22 | 0.47 (−0.08; 1.01) | 0.093 |
rs3025039 | 0.14 | −1.22 (−1.93; −0.51) | 7.45E-04 | 0.12 | 0.25 (−0.35; 0.85) | 0.418 | 0.18 | −0.04 (−0.68; 0.61) | 0.906 |
rs41282644 | 0.00 | --- | --- | 0.07 | 0.31 (−0.52; 1.13) | 0.463 | 0.10 | 1.27 (0.51; 2.03) | 1.03E-03 |
The SNPs significantly associated in the detection sample of each population are reported. The results for the SNP (*) repeatedly associated with VEGF levels and/or related diseases in the literature are also presented.
p-value threshold corrected for multiple testing = 0.003.